Passage Bio, Inc.

SecurityPASG / Passage Bio, Inc.
InsiderLynx1 Capital Management LP
This page shows the track record and history of Lynx1 Capital Management LP insider trades in Passage Bio, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Lynx1 Capital Management LP in PASG / Passage Bio, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2025-09-15 11,900 6.9895 11,900 6.9895 83,175 3 7.5500 6,670 8.02
2025-09-12 19,783 6.9908 19,783 6.9908 138,299
2025-09-11 325 6.9558 325 6.9558 2,261
2025-07-24 66,423 5.7127 66,423 5.7127 379,455
2025-07-23 49,302 5.7408 49,302 5.7408 283,033
2025-07-22 13,123 5.4361 13,123 5.4361 71,338
2024-12-27 373,645 0.6451 18,682 12.9020 241,038
2024-11-27 29,300 0.6711 1,465 13.4220 19,663
2024-11-26 167,055 0.7075 8,353 14.1500 118,191
2024-11-25 259,998 0.5641 13,000 11.2820 146,665

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PASG / Passage Bio, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Lynx1 Capital Management LP in PASG / Passage Bio, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PASG / Passage Bio, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-09-15 2025-09-15 4 Lynx1 Capital Management LP PASG Common Stock P - Purchase I 6.9895 11,900 83 623,704
2025-09-15 2025-09-12 4 Lynx1 Capital Management LP PASG Common Stock P - Purchase I 6.9908 19,783 138 611,804
2025-09-15 2025-09-11 4 Lynx1 Capital Management LP PASG Common stock, $0.0001 par value per share (Common Stock) P - Purchase I 6.9558 325 2 592,021
2025-07-24 2025-07-24 4 Lynx1 Capital Management LP PASG Common Stock P - Purchase I 5.7127 66,423 379 591,696
2025-07-24 2025-07-23 4 Lynx1 Capital Management LP PASG Common Stock P - Purchase I 5.7408 49,302 283 525,273
2025-07-24 2025-07-22 4 Lynx1 Capital Management LP PASG Common stock, $0.0001 par value per share ("Common Stock") P - Purchase I 5.4361 13,123 71 475,971
2024-12-31 2024-12-27 4 Lynx1 Capital Management LP PASG Common stock, $0.0001 par value per share P - Purchase I 0.6451 373,645 241 9,256,953
2024-11-27 2024-11-27 4 Lynx1 Capital Management LP PASG Common Stock P - Purchase I 0.6711 29,300 20 8,883,308
2024-11-27 2024-11-26 4 Lynx1 Capital Management LP PASG Common Stock P - Purchase I 0.7075 167,055 118 8,854,008
2024-11-27 2024-11-25 4 Lynx1 Capital Management LP PASG Common stock, $0.0001 par value per share ("Common Stock") P - Purchase I 0.5641 259,998 147 8,686,953
2024-08-09 3 Lynx1 Capital Management LP PASG Common stock, $0.0001 par value per share I 8,426,955
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)